aTyr Sets 1-for-40 Reverse Split as Shares Sit at $0.15
ATYR is trading near its 52-week low of $0.144 (3.6% above the low).
Summary
aTyr's board locked in a 1-for-40 reverse stock split, the specific ratio inside the 1-for-10 to 1-for-50 range shareholders authorized at the October 16 special meeting. The move is about staying listed: the stock trades around $0.15, near its 52-week low of $0.1438, and the split is aimed at regaining Nasdaq's minimum bid price. It comes after a brutal stretch — a 60% workforce cut in August, the CFO and General Counsel departures, and the loss of the Kyorin partnership and its $155M in potential milestones. The split changes nothing about the underlying business; it is a share-count mechanic that buys time while efzofitimod's Phase 3 in pulmonary sarcoidosis, aligned with the FDA in September, gets underway.
At the time of this announcement, ATYR was trading at $0.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15M. The 52-week trading range was $0.14 to $1.11. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.